News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
604,832 Results
Type
Article (45070)
Company Profile (234)
Press Release (559521)
Multimedia
Podcasts (125)
Webinars (12)
Section
Business (160164)
Career Advice (1604)
Deals (30285)
Drug Delivery (130)
Drug Development (76455)
Employer Resources (128)
FDA (15781)
Job Trends (12397)
News (289136)
Policy (31105)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (2520)
Academic (1)
Accelerated approval (34)
Adcomms (34)
Allergies (143)
Alliances (49836)
ALS (178)
Alzheimer's disease (1691)
Antibody-drug conjugate (ADC) (337)
Approvals (15968)
Artificial intelligence (525)
Autoimmune disease (169)
Automation (37)
Bankruptcy (273)
Best Places to Work (10403)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (170)
Bladder cancer (160)
Brain cancer (65)
Breast cancer (649)
Cancer (4926)
Cardiovascular disease (417)
Career advice (1364)
Career pathing (31)
CAR-T (313)
CDC (57)
Celiac Disease (1)
Cell therapy (840)
Cervical cancer (34)
Clinical research (65298)
Collaboration (1799)
Company closure (4)
Compensation (1112)
Complete response letters (71)
COVID-19 (2807)
CRISPR (99)
C-suite (802)
Cystic fibrosis (141)
Data (6199)
Decentralized trials (2)
Denatured (29)
Depression (141)
Diabetes (508)
Diagnostics (5607)
Digital health (48)
Diversity (8)
Diversity, equity & inclusion (38)
Drug discovery (259)
Drug pricing (202)
Drug shortages (34)
Duchenne muscular dystrophy (243)
Earnings (61596)
Editorial (60)
Employer branding (15)
Employer resources (120)
Events (87240)
Executive appointments (923)
FDA (18885)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (22)
Funding (1465)
Gene editing (215)
Generative AI (43)
Gene therapy (686)
GLP-1 (1048)
Government (4834)
Grass and pollen (7)
Guidances (363)
Healthcare (17109)
HIV (62)
Huntington's disease (47)
IgA nephropathy (87)
Immunology and inflammation (270)
Immuno-oncology (61)
Indications (110)
Infectious disease (3092)
Inflammatory bowel disease (185)
Inflation Reduction Act (16)
Influenza (120)
Intellectual property (240)
Interviews (262)
IPO (13846)
IRA (55)
Job creations (2390)
Job search strategy (1151)
JPM (60)
Kidney cancer (15)
Labor market (60)
Layoffs (490)
Leadership (27)
Legal (7655)
Liver cancer (90)
Longevity (14)
Lung cancer (668)
Lymphoma (383)
Machine learning (40)
Management (42)
Manufacturing (807)
MASH (171)
Medical device (12410)
Medtech (12460)
Mergers & acquisitions (17524)
Metabolic disorders (1332)
Multiple sclerosis (167)
NASH (21)
Neurodegenerative disease (339)
Neuropsychiatric disorders (98)
Neuroscience (2978)
Neurotech (1)
NextGen: Class of 2026 (5685)
Non-profit (3815)
Now hiring (29)
Obesity (647)
Opinion (289)
Ovarian cancer (163)
Pain (209)
Pancreatic cancer (230)
Parkinson's disease (292)
Partnered (30)
Patents (484)
Patient recruitment (501)
Peanut (58)
People (45005)
Pharmaceutical (51)
Pharmacy benefit managers (27)
Phase 1 (20311)
Phase 2 (28693)
Phase 3 (21828)
Pipeline (5206)
Policy (310)
Postmarket research (2347)
Preclinical (8574)
Press Release (59)
Prostate cancer (243)
Psychedelics (55)
Radiopharmaceuticals (286)
Rare diseases (902)
Real estate (4172)
Recruiting (58)
Regulatory (23213)
Reports (32)
Research institute (2347)
Resumes & cover letters (249)
Rett syndrome (28)
RNA editing (17)
RSV (84)
Schizophrenia (154)
Series A (238)
Series B (192)
Service/supplier (8)
Sickle cell disease (101)
Special edition (19)
Spinal muscular atrophy (162)
Sponsored (40)
Startups (3009)
State (1)
Stomach cancer (18)
Supply chain (101)
Tariffs (85)
The Weekly (95)
Vaccines (1110)
Venture capital (92)
Weight loss (437)
Women's health (76)
Worklife (14)
Date
Today (90)
Last 7 days (583)
Last 30 days (2039)
Last 365 days (29157)
2026 (3309)
2025 (29450)
2024 (32866)
2023 (36610)
2022 (46939)
2021 (50587)
2020 (48517)
2019 (41087)
2018 (30925)
2017 (28881)
2016 (27250)
2015 (31701)
2014 (23981)
2013 (19707)
2012 (21160)
2011 (21818)
2010 (19796)
Location
Africa (721)
Alabama (71)
Alaska (6)
Arizona (253)
Arkansas (13)
Asia (36555)
Australia (6347)
California (10710)
Canada (2903)
China (1134)
Colorado (398)
Connecticut (471)
Delaware (324)
Europe (85846)
Florida (1595)
Georgia (320)
Hawaii (4)
Idaho (53)
Illinois (774)
India (70)
Indiana (461)
Iowa (20)
Japan (433)
Kansas (108)
Kentucky (36)
Louisiana (25)
Maine (47)
Maryland (1351)
Massachusetts (7830)
Michigan (260)
Minnesota (578)
Mississippi (5)
Missouri (131)
Montana (29)
Nebraska (21)
Nevada (111)
New Hampshire (65)
New Jersey (2831)
New Mexico (28)
New York (2821)
North Carolina (1333)
North Dakota (10)
Northern California (5264)
Ohio (321)
Oklahoma (21)
Oregon (37)
Pennsylvania (2040)
Puerto Rico (22)
Rhode Island (39)
South America (975)
South Carolina (49)
South Dakota (1)
Southern California (4127)
Tennessee (146)
Texas (1650)
United States (37637)
Utah (254)
Vermont (1)
Virginia (234)
Washington D.C. (68)
Washington State (894)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
604,832 Results for "lts lohmann therapie systeme ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
October 13, 2025
·
3 min read
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US
LTS LOHMANN Therapie-Systeme AG announced that its customer Coherus BioSciences, Inc has launched its UDENYCA® on-body injector utilizing the LTS Sorrel™ wearable drug delivery platform.) UDENYCA® is a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.
February 28, 2024
·
3 min read
Press Releases
LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE
February 9, 2026
·
1 min read
Policy
Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing Medication-Assisted Treatments to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces it has signed a global licensing agreement with LTS Lohmann Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company.
December 20, 2023
·
7 min read
Press Releases
Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain
February 9, 2026
·
2 min read
Press Releases
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
February 12, 2026
·
4 min read
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
LTS LOHMANN Therapie-Systeme AG (“LTS”) has completed its acquisition of the Sorrel wearable injection device business (“Sorrel”) with headquarters in Netanya, Israel, from Eitan Medical Ltd (“Eitan Medical”).
June 8, 2023
·
2 min read
Business
PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch
PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM),, and LTS LOHMANN Therapie-Systeme AG (“LTS”), today announced they have entered into a process development agreement for the clinical trial scale up of PharmaTher’s proprietary Ketamine microneedle patch product.
December 20, 2021
·
6 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
January 5, 2026
·
9 min read
Press Releases
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
January 16, 2026
·
7 min read
1 of 60,484
Next